The U.S. is shutting out more foreign-made drones and robots. China’s scale means the global competition may simply move elsewhere.
Grindr wants to be the everything app for gay men; investors are still deciding whether it can pull it off
George Arison is done letting Wall Street’s “Grindr discount” go unchallenged — in a wide-ranging Q&A, the CEO walks us through how AI, a controversial $350-plus EDGE tier, and a bet on healthcare and long-distance matchmaking are turning Grindr into the “gayborhood in your pocket” he’s been promising since 2022.
Liux’s Big microcar bets on sustainability to take on Chinese rivals
The Liux Big microcar is made in Spain. The startup thinks it can compete in a crowded market with its tiny electric car built around sustainability.
Musk’s faster path to more gas turbines comes with pollution problem
Elon Musk says a secretive new SpaceX foundry will let him cast his own turbine blades and get gas power online 18 months faster than anyone else — but it’s a bet on a fuel source that’s already triggering lawsuits and health studies everywhere his (and others’) turbines have gone in.
TechCrunch Mobility: The hidden human cost of robotaxis
Welcome back to TechCrunch Mobility, your hub for the future of transportation and now, more than ever, the role AI is playing in it.
Caterpillar is bringing to AI deployment what it learned from automating mining
Caterpillar has spent decades putting autonomous machines to work at remote mining sites. It’s now bringing that experience to AI deployment.
Sony Music, Warner sue Anthropic, alleging a “brazen campaign” of intellectual property theft
This latest lawsuit is particularly broad and homes in on accusations of illegal piracy.
At TechBBQ, Europe’s AI conversations kept coming back to: Who’s actually in control?
Investors, founders, and operators from across Europe arrived for the annual Nordic TechBBQ conference to talk about how humans can have agency over AI.
“We’re not doing 30 bets a year”: Vijay Pande on betting small after running $4 billion at a16z
Vijay Pande — who left a16z’s roughly $4 billion biotech practice last year to start the much smaller, AI-native VZVC — talks about why biology is finally shifting from a “discovery” science to an “engineering” one, why clinical trials are still brutally expensive, and why he thinks open, shared datasets (not walled-off ones) are what will actually let AI transform…
Hollywood celebs are getting into microdrama apps
Several Hollywood celebs are ditching the massive eight-figure checks and exotic movie sets for a rising format: microdramas.